0001520773-11-000001.txt : 20110518
0001520773-11-000001.hdr.sgml : 20110518
20110518161453
ACCESSION NUMBER: 0001520773-11-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20110518
DATE AS OF CHANGE: 20110518
EFFECTIVENESS DATE: 20110518
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clovis Oncology, Inc.
CENTRAL INDEX KEY: 0001466301
IRS NUMBER: 900475355
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-142245
FILM NUMBER: 11855063
BUSINESS ADDRESS:
STREET 1: 1871 FOLSOM STREET
CITY: BOULDER
STATE: CO
ZIP: 80302
BUSINESS PHONE: (720) 220-9122
MAIL ADDRESS:
STREET 1: 1871 FOLSOM STREET
CITY: BOULDER
STATE: CO
ZIP: 80302
D/A
1
primary_doc.xml
X0704
D/A
LIVE
0001466301
Clovis Oncology, Inc.
2525 28th Street, Suite 100
BOULDER
CO
COLORADO
80301
(303) 625-5000
DELAWARE
None
None
Corporation
true
2009
Erle
T.
Mast
2525 28th Street, Suite 100
Boulder
CO
COLORADO
80301
Executive Officer
Executive Vice President, Chief Financial Officer and Secretary
Patrick
J.
Mahaffy
2525 28th Street, Suite 100
Boulder
CO
COLORADO
80301
Executive Officer
President and Chief Executive Officer
Gillian
C.
Ivers-Read
2525 28th Street, Suite 100
Boulder
CO
COLORADO
80301
Executive Officer
Executive Vice President, Regulatory Affairs and Technical Operations
Andrew
R.
Allen
2525 28th Street, Suite 100
Boulder
CO
COLORADO
80301
Executive Officer
Executive Vice President, Chief Medical Officer
Pharmaceuticals
Decline to Disclose
- 06
true
0001466301-10-000001
2009-05-15
true
true
false
0
146300000
146300000
0
false
19
0
0
0
false
Clovis Oncology, Inc.
Erle T. Mast
Erle T. Mast
See Clarification Box in Item #3 above
2011-05-18